Every compound is manufactured to research-grade standards and intended strictly for laboratory and research use. Consistent quality you can build a reproducible protocol around.
Batch number on every vial
Published Certificates of Analysis
Purity verified by third-party testing
Temperature-sensitive compounds are stored and shipped under controlled conditions, so material arrives in the state your research requires. Expert support on hand at every step.
GHRP-2 (5 mg) is a synthetic hexapeptide growth hormone secretagogue used in laboratory studies of growth hormone signaling. Research has investigated GHRP-2’s ability to stimulate pulsatile growth hormone release and influence related hormonal signals, such as insulin-like growth factor-1 (IGF-1), in experimental models of endocrine function and hypothalamic-pituitary regulation.
GHRP-2 (5mg) is supplied as a lyophilized powder in a sealed research vial. It is produced using standard research-grade synthesis methods, with its identity and purity confirmed through analytical testing such as HPLC and mass spectrometry.
The 5 mg format is suitable for pilot studies, dose-response experiments, and small-scale laboratory protocols.
For laboratory research use only.
GHRP-2 has been extensively studied as a tool for understanding how the body regulates growth hormone production. Researchers often use the peptide to examine the function of the hypothalamic-pituitary axis and how hormonal signals respond to stimulation under controlled conditions.
In endocrine research, GHRP-2 has been used in challenge tests to measure hormone responses, including growth hormone, adrenocorticotropic hormone (ACTH), and cortisol. These experiments help evaluate pituitary function and hormonal feedback systems in experimental settings.
Beyond endocrine research, scientists have also investigated how GHRP-2 may influence metabolism, cardiovascular biology, and cellular stress responses. Some experimental studies have explored its role in oxidative stress pathways and inflammatory signaling within vascular tissue.
These investigations contribute to broader GHRP-2 research aimed at understanding how endocrine signaling interacts with metabolic and cardiovascular processes.
Clinical research protocols have used single intravenous doses of GHRP-2 at microgram levels to assess growth hormone secretion in diagnostic testing settings. In these research environments, blood samples are typically collected over a short observation period to measure changes in hormone levels following administration.
Experimental animal models have been used to study the peptide's biological effects. In one study with ApoE-deficient mice, repeated exposure to GHRP-2 was associated with increased circulating IGF-1 levels and reduced markers of oxidative stress in vascular tissue, although changes in atherosclerotic plaque formation were limited.
Cell-culture experiments have further investigated how GHRP-2 may influence oxidative stress and cellular injury. Studies involving vascular smooth muscle cells and macrophages reported reductions in reactive oxygen species production and altered lipid uptake pathways when the peptide was introduced under laboratory conditions.
These observations continue to support GHRP-2’s role as a research compound for examining endocrine and metabolic signaling mechanisms.
Compliance Notice: This product is intended for laboratory research use only and is not approved for human or veterinary use. It is not intended for diagnostic, therapeutic, or clinical applications. Any reference to biological activity or potential effects is based solely on preclinical or in-vitro findings and should not be interpreted as validated clinical outcomes. Researchers are responsible for ensuring proper handling, storage, and disposal in accordance with institutional, federal, and international guidelines.
Subscribe for exclusive offers and updates on new arrivals